The company's development will be presented by Elekta's President and CEO, Gustaf Salford, together with CFO, Johan Adebäck. After the presentation, held in English, a Q&A session will follow.
The presentation will be broadcast live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta's website after the call.
Time: Thursday, November 25, at 10:00 a.m. CET
Telephone numbers to join phone conference:
UK: +44 333 300 9035
USA: +1 646 722 4902
Sweden: +46 8 566 427 06
# # #
For further information, please contact:
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail:
Time zone: CET (Central European Time)
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com (http://www.elekta.com/) or follow